ReaZedd

ReaZedd

Lifevantage pulled back to around 14$. Low risk entry point. Price is consolidating some days here. (+) great revenue increse due to new product launch in october (+) product is in the weight loss industry..a natural variant to ozempic (+) Except more revenue increase next quarter. Start from new product was mid October. (-) Due to new product launch expect lower...

ReaZedd

BioStem is a manufacturer for wound care. Innovation new product and very succesful Technical: (+) Nice run from last year (product launch), volume increasing (+) consolidation area lower volume (-) wide range consolidation Fundamental: (+) New product launch in Q4/2023. Great revenue increase last quarter. (+) Outlook Q4 > 100 Mio revenue --> except minimum...

ReaZedd

Hennessy is a provider of different funds. The top funds have a 5-star rating from morningstar. Technical: (+) textbook chart pattern (price and volume) (+) consolidation around 12$ on low volume (+) low float (-) very low volume Fundamental: (+) Good EPS increase due to a rise in the assets under management (live tracker on homepage :-) (+) Asset under...

ReaZedd

Another great insurance company Technical: (+) Weekly breakout on volume. Chart and volume pattern is very nice. (+) Consolidation on low volume at support level from previous leg. Fundamental: (+) Strong revenue increase yoy (+) EPS increase, and turnaround to EPS positive last quarter + surprise (+) Market Cap is quite low. (-) Insider selling in...

ReaZedd

Zevia is like an espreso shot..could be an fast opportunity. (+) Last quarterly wasnt impressive, but better margin and (+) expansion from 800 to 4200 walmart stores is a good story. (5-fold). (+) Also expansion into Aldi markets are mentioned. (+) small insider buying (-) negative eps (-) outstanding shares are increasing (-) we dont know if the crowd likes...

ReaZedd

Second Crack: NUTX (Nutex Health) Technical: (+) Weekly breakout on volume. (+) Consolidation towards MA50 Fundamental: (+) Revenue increase (+) EPS increase, possible turnaround candidate to EPS positive (+) cashflow positive last quarter (+) expansion is planned, every hospital makes around 10 mio/year (currently 21) (+) insider buying open market (-)...

ReaZedd

Second Crack: KINS (Kingstone Companies) Technical: (+) Weekly breakout on volume. (+) Consolidation towards MA50 Fundamental: (+) Revenue increase (+) Strong EPS increase, Turnaround (-) only turnaround, no new product Low Risk Entry: ~9$ Price target: 20$-25 $ Stopp Loss: ~8$ Second Crack Strategy: A good coffee needs the "second crack"...

ReaZedd

Second Crack: PSNL (Personalis) Technical: (+) Weekly breakout on volume. (+) Consolidation towards MA50 Fundamental: (+) New product, new partnership (+) Revenue increase (+) Strong EPS increase, could turn green in 2025 (-) currently negative EPS Low Risk Entry: ~5$ Price target: 10$-15 $ Stopp Loss: ~4.50$ Second Crack Strategy: A...